Literature DB >> 32248017

RBM4 regulates M1 macrophages polarization through targeting STAT1-mediated glycolysis.

Ning Huangfu1, Wenyuan Zheng2, Zhenyu Xu2, Shenghuang Wang2, Yong Wang2, Jingsong Cheng2, Zhenwei Li2, Ke'ai Cheng2, Shuangshuang Zhang2, Xiaomin Chen3, Jianhua Zhu4.   

Abstract

M1/M2 macrophages polarization play important roles in regulating tissue homeostasis. Recently, RNA-binding motif 4 (RBM4) has been reported to modulate the proliferation and expression of inflammatory factors in HeLa cells. However, whether RBM4 is involved in regulating macrophage polarization and inflammatory factor expression are still unknown. In this study, RAW264.7, a mouse macrophage cell line, were stimulated with interferon γ (IFN-γ) or interleukin-4 (IL-4) to induce M1/M2 macrophages polarization. We found that IFN-γ, but not IL-4, stimulation decreased RBM4 expression in macrophages, and RBM4 overexpression inhibits IFN-γ-induced M1 macrophage polarization. Furthermore, RNA-Sequencing, protein immunoprecipitation accompanied with mass spectrometry, and extracellular acidification rate analysis showed that RBM4 suppresses IFN-γ-induced M1 macrophage polarization though inhibiting glycolysis. Moreover, RBM4 knockdown promoted IFN-γ-induced signal transducer and activator of transcription 1 (STAT1) activation via increasing STAT1 mRNA stability, leading to the increase of glycolysis-related gene transcripts regulated by STAT1. Finally, we find that RBM4 interacts with YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) to degrade m6A modified STAT1 mRNA, thereby regulating glycolysis and M1 macrophage polarization. Collectively, the current study firstly reports that RBM4 regulates M1 macrophages polarization through targeting STAT1-mediated glycolysis and shows that RBM4 is a possible candidate for regulating macrophage M1 polarization and inflammatory responses.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glycolysis; Interferon γ; Macrophages polarization; RNA-binding motif 4; Signal transducer and activator of transcription 1

Mesh:

Substances:

Year:  2020        PMID: 32248017     DOI: 10.1016/j.intimp.2020.106432

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  11 in total

Review 1.  The importance of N6-methyladenosine modification in tumor immunity and immunotherapy.

Authors:  Ze Zhang; Furong Liu; Wei Chen; Zhibin Liao; Wanguang Zhang; Bixiang Zhang; Huifang Liang; Liang Chu; Zhanguo Zhang
Journal:  Exp Hematol Oncol       Date:  2022-05-19

Review 2.  Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application.

Authors:  Fusheng Zhang; Haiyang Liu; Meiqi Duan; Guang Wang; Zhenghou Zhang; Yutian Wang; Yiping Qian; Zhi Yang; Xiaofeng Jiang
Journal:  J Hematol Oncol       Date:  2022-07-06       Impact factor: 23.168

Review 3.  RNA m6A Modification in Immunocytes and DNA Repair: The Biological Functions and Prospects in Clinical Application.

Authors:  Mingjie Zhou; Wei Liu; Jieyan Zhang; Nan Sun
Journal:  Front Cell Dev Biol       Date:  2021-12-20

4.  Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer.

Authors:  Xin-Ying Zhou; Hai-Yan Dai; Hu Zhang; Jian-Long Zhu; Hua Hu
Journal:  J Clin Lab Anal       Date:  2022-03-03       Impact factor: 2.352

Review 5.  The Potential Role of m6A RNA Methylation in the Aging Process and Aging-Associated Diseases.

Authors:  Jin Sun; Bokai Cheng; Yongkang Su; Man Li; Shouyuan Ma; Yan Zhang; Anhang Zhang; Shuang Cai; Qiligeer Bao; Shuxia Wang; Ping Zhu
Journal:  Front Genet       Date:  2022-04-20       Impact factor: 4.772

6.  Inhibition of TLR4 Suppresses the Inflammatory Response in Inflammatory Bowel Disease (IBD) by Modulating the PDK1-Induced Metabolism Reprogramming via a m6A-Denpendent Manner.

Authors:  Jing Wang; Jing Huang; Liang Fang
Journal:  Comput Math Methods Med       Date:  2022-07-04       Impact factor: 2.809

Review 7.  Regulation of N6-methyladenosine (m6A) RNA methylation in microglia-mediated inflammation and ischemic stroke.

Authors:  Fangfang Zhang; Yuanyuan Ran; Muhammad Tahir; Zihan Li; Jianan Wang; Xuechai Chen
Journal:  Front Cell Neurosci       Date:  2022-08-04       Impact factor: 6.147

8.  Angelicin Alleviates Post-Trauma Osteoarthritis Progression by Regulating Macrophage Polarization via STAT3 Signaling Pathway.

Authors:  Zhansong Tian; Fanchun Zeng; Chunrong Zhao; Shiwu Dong
Journal:  Front Pharmacol       Date:  2021-06-09       Impact factor: 5.810

Review 9.  N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.

Authors:  Liting Guo; Hui Yang; Chenfei Zhou; Yan Shi; Lei Huang; Jun Zhang
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

10.  TDP43 Exacerbates Atherosclerosis Progression by Promoting Inflammation and Lipid Uptake of Macrophages.

Authors:  Ning Huangfu; Yong Wang; Zhenyu Xu; Wenyuan Zheng; Chunlan Tao; Zhenwei Li; Yewen Hu; Xiaomin Chen
Journal:  Front Cell Dev Biol       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.